{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:51:53Z","timestamp":1791805913293,"version":"4.3.4"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["24KJB180015"],"award-info":[{"award-number":["24KJB180015"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bcp.2025.117286","type":"journal-article","created":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T23:16:58Z","timestamp":1756768618000},"page":"117286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Non-coding RNAs-glycolysis axis in cancer therapy resistance: Insight into mechanism to therapeutic solution"],"prefix":"10.1016","volume":"242","author":[{"given":"Jiachen","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinzheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuruliarizki Shinta","family":"Pandupuspitasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheem Ahmed","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7784-6325","authenticated-orcid":false,"given":"Chunjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.117286_b0005","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a cancer journal for clinicians. 2018;68(6):394-424.","DOI":"10.3322\/caac.21492"},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0010","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a040535","article-title":"Glycolysis","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"22","key":"10.1016\/j.bcp.2025.117286_b0015","doi-asserted-by":"crossref","first-page":"6921","DOI":"10.1158\/0008-5472.CAN-11-1457","article-title":"Lactate: a metabolic key player in cancer","volume":"71","author":"Hirschhaeuser","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117286_b0020","article-title":"Photo-thermally controllable tumor metabolic modulation to assist T cell activation for boosting immunotherapy","volume":"11181\u201394","author":"Ma","year":"2024","journal-title":"Int. J. Nanomed."},{"issue":"7","key":"10.1016\/j.bcp.2025.117286_b0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132285","article-title":"Inhibition of aerobic glycolysis represses Akt\/mTOR\/HIF-1\u03b1 axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells","volume":"10","author":"Woo","year":"2015","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bcp.2025.117286_b0030","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23151","article-title":"MiR\u2010146a\u20105p accelerates sepsis through dendritic cell activation and glycolysis via targeting ATG7","volume":"36","author":"Yu","year":"2022","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0035","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.3390\/ijms22094716","article-title":"Hexokinase 2 in cancer: a prima donna playing multiple characters","volume":"22","author":"Ciscato","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2025.117286_b0040","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.1111\/cas.14614","article-title":"Hypoxia\u2010inducible hexokinase\u20102 enhances anti\u2010apoptotic function via activating autophagy in multiple myeloma","volume":"111","author":"Ikeda","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2025.117286_b0045","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3389\/fonc.2017.00313","article-title":"Metabolic plasiticy in cancers\u2014distinct role of glycolytic enzymes GPI, LDHs or membrane transporters MCTs","volume":"7","author":"\u017ddralevi\u0107","year":"2017","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0050","first-page":"1","article-title":"Roles of PFKFB3 in cancer","volume":"2","author":"Shi","year":"2017","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7558","key":"10.1016\/j.bcp.2025.117286_b0055","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature14405","article-title":"Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations","volume":"523","author":"Webb","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0060","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.bbrc.2018.02.123","article-title":"Aldolase a overexpression is associated with poor prognosis and promotes tumor progression by the epithelial-mesenchymal transition in colon cancer","volume":"497","author":"Ye","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"14","key":"10.1016\/j.bcp.2025.117286_b0065","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1080\/15384101.2016.1179037","article-title":"PGK1 is a new member of the protein kinome","volume":"15","author":"Li","year":"2016","journal-title":"Cell Cycle"},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2019.08.006","article-title":"PTEN suppresses glycolysis by dephosphorylating and inhibiting autophosphorylated PGK1","volume":"76","author":"Qian","year":"2019","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0075","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.aninu.2016.02.005","article-title":"Progress in the biological function of alpha-enolase","volume":"2","author":"Ji","year":"2016","journal-title":"Anim. Nutr."},{"key":"10.1016\/j.bcp.2025.117286_b0080","doi-asserted-by":"crossref","unstructured":"Li Y-h, Li X-f, Liu J-t, Wang H, Fan L-l, Li J, et al. PKM2, a potential target for regulating cancer. Gene. 2018;668:48-53.","DOI":"10.1016\/j.gene.2018.05.038"},{"issue":"10","key":"10.1016\/j.bcp.2025.117286_b0085","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/1535-7163.MCT-19-0079","article-title":"Metabolic flexibility in cancer: targeting the pyruvate dehydrogenase kinase: pyruvate dehydrogenase axis","volume":"18","author":"Woolbright","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"8","key":"10.1016\/j.bcp.2025.117286_b0090","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1172\/JCI32278","article-title":"ErbB receptors: from oncogenes to targeted cancer therapies","volume":"117","author":"Zhang","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/1878-0261.12155","article-title":"Emerging functions of the EGFR in cancer","volume":"12","author":"Sigismund","year":"2018","journal-title":"Mol. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0100","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1158\/0008-5472.CAN-15-2478","article-title":"EGFR signaling enhances aerobic glycolysis in triple-negative breast cancer cells to promote tumor growth and immune escape","volume":"76","author":"Lim","year":"2016","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.bcp.2025.117286_b0105","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1111\/cns.14300","article-title":"HIF\u20101\u03b1 promotes astrocytic production of macrophage migration inhibitory factor following spinal cord injury","volume":"29","author":"Hao","year":"2023","journal-title":"CNS Neurosci. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0110","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.apsb.2015.05.007","article-title":"HIF-1\u03b1 pathway: role, regulation and intervention for cancer therapy","volume":"5","author":"Masoud","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088955","article-title":"Proline-hydroxylated hypoxia-inducible factor 1\u03b1 (HIF-1\u03b1) upregulation in human tumours","volume":"9","author":"Snell","year":"2014","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0120","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2174\/138955709788922610","article-title":"HIF-1\u03b1 modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms","volume":"9","author":"Marin-Hernandez","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.bcp.2025.117286_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116342","article-title":"Prolyl hydroxylase inhibitor FG-4592 alleviates neuroinflammation via HIF-1\/BNIP3 signaling in microglia","volume":"173","author":"Ruan","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117286_b0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176601","article-title":"Hypoxia-induced TRPM7 promotes glycolytic metabolism and progression in hepatocellular carcinoma","volume":"974","author":"Zhao","year":"2024","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0135","first-page":"174","article-title":"The effect of HIF-1alpha on glucose metabolism, growth and apoptosis of pancreatic cancerous cells","volume":"23","author":"He","year":"2014","journal-title":"Asia Pac. J. Clin. Nutr."},{"issue":"7","key":"10.1016\/j.bcp.2025.117286_b0140","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/cac2.12158","article-title":"The role of the HIF\u20101\u03b1\/ALYREF\/PKM2 axis in glycolysis and tumorigenesis of bladder cancer","volume":"41","author":"Wang","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.bcp.2025.117286_b0145","doi-asserted-by":"crossref","DOI":"10.1152\/physrev.00011.2008","article-title":"AMPK in health and disease","author":"Steinberg","year":"2009","journal-title":"Physiol. Rev."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0150","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2008.11.008","article-title":"The glycogen-binding domain on the AMPK \u03b2 subunit allows the kinase to act as a glycogen sensor","volume":"9","author":"McBride","year":"2009","journal-title":"Cell Metab."},{"issue":"10","key":"10.1016\/j.bcp.2025.117286_b0155","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/iub.387","article-title":"Metabolic functions of AMPK: aspects of structure and of natural mutations in the regulatory gamma subunits","volume":"62","author":"Moffat","year":"2010","journal-title":"IUBMB Life"},{"issue":"41","key":"10.1016\/j.bcp.2025.117286_b0160","doi-asserted-by":"crossref","first-page":"30107","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.bcp.2025.117286_b0165","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.1016\/j.apsb.2021.07.006","article-title":"Ablation of Akt2 and AMPK\u03b12 rescues high fat diet-induced obesity and hepatic steatosis through Parkin-mediated mitophagy","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.bcp.2025.117286_b0170","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1002\/1878-0261.13211","article-title":"A novel AMPK activator shows therapeutic potential in hepatocellular carcinoma by suppressing HIF1\u03b1\u2010mediated aerobic glycolysis","volume":"16","author":"Tseng","year":"2022","journal-title":"Mol. Oncol."},{"issue":"11","key":"10.1016\/j.bcp.2025.117286_b0175","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/onc.2016.304","article-title":"Wnt signaling in cancer","volume":"36","author":"Zhan","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0180","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41419-021-03739-z","article-title":"WNT\/\u03b2-catenin-suppressed FTO expression increases m6A of c-Myc mRNA to promote tumor cell glycolysis and tumorigenesis","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0185","article-title":"Tankyrase promotes aerobic glycolysis and proliferation of ovarian cancer through activation of Wnt\/\u03b2\u2010catenin signaling","volume":"2019","author":"Yang","year":"2019","journal-title":"Biomed Res. Int."},{"issue":"5930","key":"10.1016\/j.bcp.2025.117286_b0190","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0195","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","article-title":"The Warburg effect: how does it benefit cancer cells?","volume":"41","author":"Liberti","year":"2016","journal-title":"Trends Biochem. Sci"},{"issue":"13","key":"10.1016\/j.bcp.2025.117286_b0200","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1111\/bph.12668","article-title":"Increased drug resistance is associated with reduced glucose levels and an enhanced glycolysis phenotype","volume":"171","author":"Bhattacharya","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117286_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109521","article-title":"Glycolysis promotes the progression of pancreatic cancer and reduces cancer cell sensitivity to gemcitabine","volume":"121","author":"Dai","year":"2020","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0210","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1111\/jcmm.13126","article-title":"Up\u2010regulation of glycolysis promotes the stemness and EMT phenotypes in gemcitabine\u2010resistant pancreatic cancer cells","volume":"21","author":"Zhao","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2025.117286_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105110","article-title":"Hsa-miR-4271 downregulates the expression of constitutive androstane receptor and enhances in vivo the sensitivity of non-small cell lung cancer to gefitinib","volume":"161","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117286_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116295","article-title":"Angelica sinensis polysaccharide suppresses the Wnt\/\u03b2-catenin-mediated malignant biological behaviors of breast cancer cells via the miR-3187-3p\/PCDH10 axis","volume":"225","author":"Cai","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0225","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.2174\/1570159X21666230407124146","article-title":"A comprehensive review on the importance of MiRNA-206 in the animal model and human diseases","volume":"22","author":"Qi","year":"2024","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0230","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2009","journal-title":"Genome Res."},{"key":"10.1016\/j.bcp.2025.117286_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112063","article-title":"An extensive overview of the role of lncRNAs generated from immune cells in the etiology of cancer","volume":"133","author":"Luo","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2025.117286_b0240","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/gepi.21802","article-title":"The ENCODE project and perspectives on pathways","volume":"38","author":"Tragante","year":"2014","journal-title":"Genet. Epidemiol."},{"key":"10.1016\/j.bcp.2025.117286_b0245","article-title":"Suppressing circ_0008494 inhibits HSCs activation by regulating the miR-185-3p\/Col1a1 axis","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117286_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110121","article-title":"Hsa_circ_0073453 modulates IL-8 secretion by GC-MSCs to promote gastric cancer progression by sponging miR-146a-5p","volume":"119","author":"Wu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117286_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112873","article-title":"CircGNAO1 suppresses hepatocellular carcinoma progression and metastasis via sponging miR-182-5p and regulating FOXO1 expression","volume":"140","author":"Ju","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117286_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107127","article-title":"CircBIRC6 facilitates the malignant progression via miR-488\/GRIN2D-mediated CAV1-autophagy signal axis in gastric cancer","volume":"202","author":"Tang","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.bcp.2025.117286_b0265","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14902","article-title":"Role of the circRNA_34414\/miR\u20106960a\u20105p\/SIRT3 axis in postoperative delirium via CA1 Vglut1+ neurons in older mice","volume":"30","author":"Wang","year":"2024","journal-title":"CNS Neurosci. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2025.117286_b0270","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41581-021-00465-9","article-title":"Circular RNAs in kidney disease and cancer","volume":"17","author":"van Zonneveld","year":"2021","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.bcp.2025.117286_b0275","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.biopha.2018.04.098","article-title":"MiR-125b-5p suppressed the glycolysis of laryngeal squamous cell carcinoma by down-regulating hexokinase-2","volume":"103","author":"Hui","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"21","key":"10.1016\/j.bcp.2025.117286_b0280","doi-asserted-by":"crossref","first-page":"8122","DOI":"10.1002\/cam4.3322","article-title":"LncRNA LINC00857 regulates the progression and glycolysis in ovarian cancer by modulating the Hippo signaling pathway","volume":"9","author":"Lin","year":"2020","journal-title":"Cancer Med."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0285","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23578","article-title":"Mir\u2010488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3","volume":"35","author":"Deng","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.bcp.2025.117286_b0290","doi-asserted-by":"crossref","first-page":"3607","DOI":"10.2147\/OTT.S242929","article-title":"MiR-138 suppresses the PDK1 expression to decrease the oxaliplatin resistance of colorectal cancer","author":"Wang","year":"2020","journal-title":"OncoTarget. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0295","doi-asserted-by":"crossref","first-page":"e9330","DOI":"10.1590\/1414-431x20209330","article-title":"MicroRNA-4290 suppresses PDK1-mediated glycolysis to enhance the sensitivity of gastric cancer cell to cisplatin","volume":"53","author":"Qian","year":"2020","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0300","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s12013-014-0062-x","article-title":"Overexpression of microRNA-122 re-sensitizes 5-FU-resistant colon cancer cells to 5-FU through the inhibition of PKM2 in vitro and in vivo","volume":"70","author":"He","year":"2014","journal-title":"Cell Biochem. Biophys."},{"issue":"4","key":"10.1016\/j.bcp.2025.117286_b0305","first-page":"765","article-title":"MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2025.117286_b0310","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.3892\/mmr.2016.4974","article-title":"Sensitization of hepatocellular carcinoma cells to irradiation by miR\u201134a through targeting lactate dehydrogenase\u2011a","volume":"13","author":"Li","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0315","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3892\/mmr.2014.2271","article-title":"Overexpression of microRNA-125b sensitizes human hepatocellular carcinoma cells to 5-fluorouracil through inhibition of glycolysis by targeting hexokinase II","volume":"10","author":"Jiang","year":"2014","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.bcp.2025.117286_b0320","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41419-020-03123-3","article-title":"The miR-30a-5p\/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma","volume":"11","author":"Zhang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0325","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20171383","article-title":"Overexpression of miR-202 resensitizes imatinib resistant chronic myeloid leukemia cells through targetting Hexokinase 2","volume":"38","author":"Deng","year":"2018","journal-title":"Biosci. Rep."},{"issue":"28","key":"10.1016\/j.bcp.2025.117286_b0330","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1038\/s41388-019-0817-3","article-title":"The miR-186-3p\/EREG axis orchestrates tamoxifen resistance and aerobic glycolysis in breast cancer cells","volume":"38","author":"He","year":"2019","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0335","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.3171\/2018.12.JNS181798","article-title":"Effect of glycolysis inhibition by miR-448 on glioma radiosensitivity","volume":"132","author":"Lan","year":"2019","journal-title":"J. Neurosurg."},{"issue":"4","key":"10.1016\/j.bcp.2025.117286_b0340","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.3892\/ol.2016.4316","article-title":"Overexpression of microRNA-133b sensitizes non-small cell lung cancer cells to irradiation through the inhibition of glycolysis","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0345","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s40164-022-00322-w","article-title":"TRIM family contribute to tumorigenesis, cancer development, and drug resistance","volume":"11","author":"Huang","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bcp.2025.117286_b0350","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.813793","article-title":"Effects of miR-103a-3p targeted regulation of TRIM66 Axis on Docetaxel resistance and glycolysis in prostate Cancer cells","volume":"12","author":"Yi","year":"2022","journal-title":"Front. Genet."},{"issue":"48","key":"10.1016\/j.bcp.2025.117286_b0355","doi-asserted-by":"crossref","first-page":"83660","DOI":"10.18632\/oncotarget.19014","article-title":"microRNA-33a-5p increases radiosensitivity by inhibiting glycolysis in melanoma","volume":"8","author":"Cao","year":"2017","journal-title":"Oncotarget"},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0360","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1038\/s41416-020-0773-2","article-title":"miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer","volume":"122","author":"Barisciano","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0365","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14715\/cmb\/2017.63.9.14","article-title":"miR-214 modulates cisplatin sensitivity of osteosarcoma cells through regulation of anaerobic glycolysis","volume":"63","author":"Song","year":"2017","journal-title":"Cell. Mol. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0370","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1631\/jzus.B1800190","article-title":"MiR-1180 from bone marrow-derived mesenchymal stem cells induces glycolysis and chemoresistance in ovarian cancer cells by upregulating the Wnt signaling pathway","volume":"20","author":"Gu","year":"2019","journal-title":"J. Zhejiang Universi.-Sci. B."},{"key":"10.1016\/j.bcp.2025.117286_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119798","article-title":"MiR-223-3p targets FOXO3a to inhibit radiosensitivity in prostate cancer by activating glycolysis","volume":"282","author":"Zhou","year":"2021","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0380","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.3892\/mmr.2016.5394","article-title":"Inhibition of microRNA-155 sensitizes lung cancer cells to irradiation via suppression of HK2-modulated glucose metabolism","volume":"14","author":"Lv","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0385","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.3892\/mmr.2016.5010","article-title":"MicroRNA-21 modulates radiation resistance through upregulation of hypoxia-inducible factor-1\u03b1-promoted glycolysis in non-small cell lung cancer cells","volume":"13","author":"Jiang","year":"2016","journal-title":"Mol. Med. Rep."},{"issue":"suppl_1","key":"10.1016\/j.bcp.2025.117286_b0390","doi-asserted-by":"crossref","first-page":"D119","DOI":"10.1093\/nar\/gkp803","article-title":"TransmiR: a transcription factor\u2013microRNA regulation database","volume":"38","author":"Wang","year":"2010","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.108950","article-title":"TBX15 facilitates malignant progression of glioma by transcriptional activation of TXDNC5","volume":"27","author":"Ge","year":"2024","journal-title":"Iscience"},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0400","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/s12935-021-02235-w","article-title":"TBX15\/miR-152\/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination","volume":"21","author":"Jiang","year":"2021","journal-title":"Cancer Cell Int."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0405","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/cbin.11714","article-title":"Long noncoding RNA HAGLR sponges miR\u2010338\u20103p to promote 5\u2010Fu resistance in gastric cancer through targeting the LDHA\u2010glycolysis pathway","volume":"46","author":"Hu","year":"2022","journal-title":"Cell Biol. Int."},{"issue":"4","key":"10.1016\/j.bcp.2025.117286_b0410","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3233\/CBM-201740","article-title":"LncRNA XIST\/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1","volume":"30","author":"Zheng","year":"2021","journal-title":"Cancer Biomark."},{"issue":"9\u201310","key":"10.1016\/j.bcp.2025.117286_b0415","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1159\/000512621","article-title":"He L-f, Zhao G-f. LncRNA XIST contributes to cisplatin resistance of lung cancer cells by promoting cellular glycolysis through sponging miR-101-3p","volume":"106","author":"Hua","year":"2021","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0420","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/1120009X.2022.2157618","article-title":"LncRNA-SNHG1 promotes paclitaxel resistance of gastric cancer cells through modulating the miR-216b-5p-hexokianse 2 axis","volume":"35","author":"Xu","year":"2023","journal-title":"J. Chemother."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0425","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/CBM-201621","article-title":"LncRNA-SNHG7 interferes with miR-34a to de-sensitize gastric cancer cells to cisplatin","volume":"30","author":"Pei","year":"2021","journal-title":"Cancer Biomark."},{"key":"10.1016\/j.bcp.2025.117286_b0430","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3389\/fonc.2020.01034","article-title":"LncRNA-DANCR interferes with miR-125b-5p\/HK2 axis to desensitize colon cancer cells to cisplatin vis activating anaerobic glycolysis","volume":"10","author":"Shi","year":"2020","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.bcp.2025.117286_b0435","doi-asserted-by":"crossref","first-page":"5707","DOI":"10.1111\/jcmm.15233","article-title":"HOTAIR\/miR\u2010125 axis\u2010mediated Hexokinase 2 expression promotes chemoresistance in human glioblastoma","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bcp.2025.117286_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120810","article-title":"Long non-coding RNA ANRIL promotes chemoresistance in triple-negative breast cancer via enhancing aerobic glycolysis","volume":"306","author":"Ma","year":"2022","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.bcp.2025.117286_b0445","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1002\/jcb.26899","article-title":"Knockdown of LncRNA\u2010UCA1 suppresses chemoresistance of pediatric AML by inhibiting glycolysis through the microRNA\u2010125a\/hexokinase 2 pathway","volume":"119","author":"Zhang","year":"2018","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2025.117286_b0450","article-title":"Long non-coding RNA TMPO-AS1 promotes GLUT1-mediated glycolysis and paclitaxel resistance in endometrial cancer cells by interacting with miR-140 and miR-143","volume":"12","author":"Dong","year":"2022","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0455","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41419-021-03523-z","article-title":"Long noncoding RNA LINC00518 induces radioresistance by regulating glycolysis through an miR-33a-3p\/HIF-1\u03b1 negative feedback loop in melanoma","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"13","key":"10.1016\/j.bcp.2025.117286_b0460","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.7150\/jca.86940","article-title":"circROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis","volume":"14","author":"Zhou","year":"2023","journal-title":"J. Cancer"},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0465","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1080\/1120009X.2023.2253680","article-title":"CircAGFG1 absence decreases PKM2 expression to enhance oxaliplatin sensitivity in colorectal cancer in a miR-7-5p-dependent manner","volume":"36","author":"Chen","year":"2024","journal-title":"J. Chemother."},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0470","first-page":"6076","article-title":"Circular RNA circUBE2D2 functions as an oncogenic factor in hepatocellular carcinoma sorafenib resistance and glycolysis","volume":"13","author":"Huang","year":"2021","journal-title":"Am. J. Transl. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0475","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3892\/ol.2021.13100","article-title":"Circular RNA FOXO3 accelerates glycolysis and improves cisplatin sensitivity in lung cancer cells via the miR-543\/Foxo3 axis","volume":"22","author":"Zhang","year":"2021","journal-title":"Oncol. Lett."},{"issue":"8","key":"10.1016\/j.bcp.2025.117286_b0480","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41419-022-05175-z","article-title":"CircKIF4A promotes glioma growth and temozolomide resistance by accelerating glycolysis","volume":"13","author":"Luo","year":"2022","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.bcp.2025.117286_b0485","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s10529-020-02846-9","article-title":"CircAKT3 inhibits glycolysis balance in lung cancer cells by regulating miR-516b-5p\/STAT3 to inhibit cisplatin sensitivity","volume":"42","author":"Xu","year":"2020","journal-title":"Biotechnol. Lett"},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0490","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/15384101.2021.2015671","article-title":"CircGOT1 promotes cell proliferation, mobility, and glycolysis-mediated cisplatin resistance via inhibiting its host gene GOT1 in esophageal squamous cell cancer","volume":"21","author":"Zhou","year":"2022","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2025.117286_b0495","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.2147\/CMAR.S257441","article-title":"Circ-ZNF609 accelerates the radioresistance of prostate cancer cells by promoting the glycolytic metabolism through miR-501-3p\/HK2 axis","author":"Du","year":"2020","journal-title":"Cancer Manag. Res."},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0500","first-page":"477","article-title":"Circle RNA circABCB10 modulates PFN2 to promote breast cancer progression, as well as aggravate radioresistance through facilitating glycolytic metabolism via miR-223-3p","volume":"36","author":"Zhao","year":"2021","journal-title":"Cancer Biother. Radiopharm."},{"issue":"8","key":"10.1016\/j.bcp.2025.117286_b0505","first-page":"558","article-title":"Serum exosomes-based biomarker circ_0008928 regulates cisplatin sensitivity, tumor progression, and glycolysis metabolism by miR-488\/HK2 axis in cisplatin-resistant nonsmall cell lung carcinoma","volume":"38","author":"Shi","year":"2023","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0510","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.bi.62.070193.001351","article-title":"Determination of RNA structure and thermodynamics","volume":"62","author":"Jaeger","year":"1993","journal-title":"Annu. Rev. Biochem"},{"issue":"5","key":"10.1016\/j.bcp.2025.117286_b0515","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1158\/0008-5472.CAN-21-2988","article-title":"EIF4A3-induced circARHGAP29 promotes aerobic glycolysis in docetaxel-resistant prostate cancer through IGF2BP2\/c-Myc\/LDHA signaling","volume":"82","author":"Jiang","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117286_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101751","article-title":"Long noncoding RNA BBOX1-AS1 increased radiotherapy sensitivity in colorectal cancer by stabilizing and activating PFK1","volume":"36","author":"Wang","year":"2023","journal-title":"Transl. Oncol."},{"issue":"22","key":"10.1016\/j.bcp.2025.117286_b0525","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/0008-5472.CAN-21-0281","article-title":"LncRNA HIF1A-AS1 promotes gemcitabine resistance of pancreatic cancer by enhancing glycolysis through modulating the AKT\/YB1\/HIF1\u03b1 pathway","volume":"81","author":"Xu","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117286_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120328","article-title":"KHDRBS3 promotes paclitaxel resistance and induces glycolysis through modulated MIR17HG\/CLDN6 signaling in epithelial ovarian cancer","volume":"293","author":"Wu","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bcp.2025.117286_b0535","article-title":"SNHG1, interacting with SND1, contributes to sorafenib resistance of liver cancer cells by increasing m6A\u2010mediated SLC7A11 expression and promoting aerobic glycolysis","author":"Li","year":"2023","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.bcp.2025.117286_b0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175444","article-title":"Implication of lncRNA ZBED3-AS1 downregulation in acquired resistance to Temozolomide and glycolysis in glioblastoma","volume":"938","author":"Dong","year":"2023","journal-title":"Eur. J. Pharmacol."},{"issue":"33","key":"10.1016\/j.bcp.2025.117286_b0545","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1038\/s41388-022-02386-8","article-title":"CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1","volume":"41","author":"Zhang","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117286_b0550","article-title":"Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2","volume":"1\u201319","author":"Li","year":"2021","journal-title":"Cell Biol. Toxicol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0555","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3233\/CBM-191181","article-title":"LncRNA-SARCC sensitizes osteosarcoma to cisplatin through the miR-143-mediated glycolysis inhibition by targeting Hexokinase 2","volume":"28","author":"Wen","year":"2020","journal-title":"Cancer Biomark."},{"issue":"20","key":"10.1016\/j.bcp.2025.117286_b0560","doi-asserted-by":"crossref","first-page":"5739","DOI":"10.7150\/thno.37556","article-title":"Decreased expression of mitochondrial miR-5787 contributes to chemoresistance by reprogramming glucose metabolism and inhibiting MT-CO3 translation","volume":"9","author":"Chen","year":"2019","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0565","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1158\/0008-5472.CAN-18-2505","article-title":"Mitochondrial miRNA determines chemoresistance by reprogramming metabolism and regulating mitochondrial transcription","volume":"79","author":"Fan","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2025.117286_b0570","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109066","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells regulate lymphangiogenesis via the miR-302d-3p\/VEGFR3\/AKT axis to ameliorate inflammatory bowel disease","volume":"110","author":"Zhang","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0575","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1021\/acs.molpharmaceut.2c00407","article-title":"Immune-cell-derived exosomes for cancer therapy","volume":"19","author":"Zhao","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.bcp.2025.117286_b0580","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2019.12.005","article-title":"Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis","volume":"318","author":"Zhao","year":"2020","journal-title":"J. Control. Release"},{"issue":"9","key":"10.1016\/j.bcp.2025.117286_b0585","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.3390\/pharmaceutics13091493","article-title":"M1 macrophage-derived exosomes loaded with gemcitabine and deferasirox against chemoresistant pancreatic cancer","volume":"13","author":"Zhao","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bcp.2025.117286_b0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2022.100915","article-title":"Exosomal LOC85009 inhibits docetaxel resistance in lung adenocarcinoma through regulating ATG5-induced autophagy","volume":"67","author":"Yu","year":"2023","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.bcp.2025.117286_b0595","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1365928","article-title":"Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression","volume":"15","author":"Qin","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.117286_b0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113397","article-title":"Exosomes derived from primary cartilage stem\/progenitor cells promote the repair of osteoarthritic chondrocytes by modulating immune responses","volume":"143","author":"Chen","year":"2024","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2025.117286_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106135","article-title":"Exosomal ncRNAs: Novel therapeutic target and biomarker for diabetic complications","volume":"178","author":"Xu","year":"2022","journal-title":"Pharmacol. Res."},{"issue":"10","key":"10.1016\/j.bcp.2025.117286_b0610","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/cbin.11671","article-title":"Exosomal miR\u201021\u20105p derived from cisplatin\u2010resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1","volume":"45","author":"Zhuang","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0615","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/1878-0261.12629","article-title":"Exosome\u2010delivered circRNA promotes glycolysis to induce chemoresistance through the miR\u2010122\u2010PKM2 axis in colorectal cancer","volume":"14","author":"Wang","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.bcp.2025.117286_b0620","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.620603","article-title":"Exosomes derived from macrophages enhance aerobic glycolysis and chemoresistance in lung cancer by stabilizing c-Myc via the inhibition of NEDD4L","volume":"8","author":"Wang","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"36","key":"10.1016\/j.bcp.2025.117286_b0625","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41388-021-01960-w","article-title":"Hypoxic exosomal HIF-1\u03b1-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis","volume":"40","author":"Zeng","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117286_b0630","article-title":"Exosome-derived circ_0094343 promotes chemosensitivity of colorectal cancer cells by regulating glycolysis via the miR-766-5p\/TRIM67 axis","volume":"2022","author":"Li","year":"2022","journal-title":"Contrast Media Mol. Imaging"},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0635","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s43440-019-00012-1","article-title":"Cleistanthin a inhibits the invasion of MDA-MB-231 human breast cancer cells: Involvement of the \u03b2-catenin pathway","volume":"72","author":"Liu","year":"2020","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bcp.2025.117286_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108222","article-title":"Wogonin inhibits the growth of HT144 melanoma via regulating hedgehog signaling-mediated inflammation and glycolysis","volume":"101","author":"Li","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2025.117286_b0645","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1021\/acs.jnatprod.1c00618","article-title":"A derivative of piperlongumine and ligustrazine as a potential thioredoxin reductase inhibitor in drug-resistant hepatocellular carcinoma","volume":"84","author":"Qian","year":"2021","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0650","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2174\/1573406416666201120102250","article-title":"2, 4, 5-trideoxyhexopyranosides derivatives of 4\u2019-demethylepipodophyllotoxin: de novo synthesis and anticancer activity","volume":"18","author":"Lu","year":"2022","journal-title":"Med. Chem."},{"key":"10.1016\/j.bcp.2025.117286_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154732","article-title":"Active post-transcriptional regulation and ACLY-mediated acetyl-CoA synthesis as a pivotal target of Shuang-Huang-Sheng-Bai formula for lung adenocarcinoma treatment","volume":"113","author":"Liu","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117286_b0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155427","article-title":"Uncovering the effect and mechanism of Jiawei Xiaoyao Wan in treating breast cancer complicated with depression based on network pharmacology and experimental analysis","volume":"128","author":"Bai","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bcp.2025.117286_b0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116708","article-title":"Natural products as glycolytic inhibitors for cervical cancer treatment: a comprehensive review","volume":"175","author":"Liu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.117286_b0670","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.biocel.2014.05.021","article-title":"Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer","volume":"53","author":"Li","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.bcp.2025.117286_b0675","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11101-013-9327-z","article-title":"Overcoming chemotherapy resistance with herbal medicines: past, present and future perspectives","volume":"13","author":"Wang","year":"2014","journal-title":"Phytochem. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0680","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.3390\/cancers13061274","article-title":"Regulation of long non-coding RNAs by plant secondary metabolites: a novel anticancer therapeutic approach","volume":"13","author":"Kalhori","year":"2021","journal-title":"Cancers"},{"issue":"16","key":"10.1016\/j.bcp.2025.117286_b0685","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.3390\/molecules28166118","article-title":"Pharmacological effects of astragaloside IV: a review","volume":"28","author":"Liang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117286_b0690","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.2147\/CMAR.S297008","article-title":"Astragalus IV undermines multi-drug resistance and glycolysis of MDA-MB-231\/ADR cell line by depressing hsa_circ_0001982-miR-206\/miR-613 Axis","author":"Li","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bcp.2025.117286_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.05.002","article-title":"Kaempferol and inflammation: from chemistry to medicine","volume":"99","author":"Devi","year":"2015","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.117286_b0700","doi-asserted-by":"crossref","unstructured":"M Calderon-Montano J, Burgos-Mor\u00f3n E, P\u00e9rez-Guerrero C, L\u00f3pez-L\u00e1zaro M. A review on the dietary flavonoid kaempferol. Mini Rev. Med. Chem. 2011;11(4):298-344.","DOI":"10.2174\/138955711795305335"},{"issue":"7","key":"10.1016\/j.bcp.2025.117286_b0705","doi-asserted-by":"crossref","first-page":"3544","DOI":"10.3390\/ijms23073544","article-title":"Kaempferol can reverse the 5-Fu resistance of colorectal cancer cells by inhibiting PKM2-mediated glycolysis","volume":"23","author":"Wu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2025.117286_b0710","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1995-7645(12)60185-0","article-title":"Dauricine can inhibit the activity of proliferation of urinary tract tumor cells","volume":"5","author":"Wang","year":"2012","journal-title":"Asian Pac. J. Trop. Med."},{"issue":"6","key":"10.1016\/j.bcp.2025.117286_b0715","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.3390\/molecules28062701","article-title":"Research progress on chemical constituents and pharmacological activities of Menispermi rhizoma","volume":"28","author":"Zhai","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.bcp.2025.117286_b0720","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.fct.2018.08.030","article-title":"Dauricine upregulates the chemosensitivity of hepatocellular carcinoma cells: Role of repressing glycolysis via miR-199a: HK2\/PKM2 modulation","volume":"121","author":"Li","year":"2018","journal-title":"Food Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.bcp.2025.117286_b0725","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2025.117286_b0730","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1128312","article-title":"Metabolic reprogramming induced by DCA enhances cisplatin sensitivity through increasing mitochondrial oxidative stress in cholangiocarcinoma","volume":"14","author":"Qin","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2025.117286_b0735","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41388-019-1035-8","article-title":"Dichloroacetate restores colorectal cancer chemosensitivity through the p53\/miR-149-3p\/PDK2-mediated glucose metabolic pathway","volume":"39","author":"Liang","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2025.117286_b0740","unstructured":"Schrodinger L. The PyMOL molecular graphics system. Version. 2015;1:8."},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0745","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s41589-024-01719-w","article-title":"Engineering artificial non-coding RNAs for targeted protein degradation","volume":"21","author":"Cao","year":"2025","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2025.117286_b0750","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2018.02.038","article-title":"Synthetic artificial\u201c long non-coding RNAs\u201d targeting oncogenic microRNAs and transcriptional factors inhibit malignant phenotypes of bladder cancer cells","volume":"422","author":"Xie","year":"2018","journal-title":"Cancer Lett."},{"issue":"45","key":"10.1016\/j.bcp.2025.117286_b0755","doi-asserted-by":"crossref","first-page":"73257","DOI":"10.18632\/oncotarget.12304","article-title":"An artificial lncRNA targeting multiple miRNAs overcomes sorafenib resistance in hepatocellular carcinoma cells","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.bcp.2025.117286_b0760","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nbt.3802","article-title":"Overcoming cellular barriers for RNA therapeutics","volume":"35","author":"Dowdy","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.bcp.2025.117286_b0765","first-page":"1","article-title":"Innovations in RNA therapeutics: a review of recent advances and emerging technologies","author":"Dweh","year":"2025","journal-title":"Nucleosid. Nucleotid. Nucl. Acid."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225005519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T08:36:05Z","timestamp":1761381365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225005519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":153,"alternative-id":["S0006295225005519"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117286","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-coding RNAs-glycolysis axis in cancer therapy resistance: Insight into mechanism to therapeutic solution","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.117286","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117286"}}